What is the severity of CVE-2017-1217?

CVE-2017-1217 has been rated as a medium severity vulnerability due to its potential impact on user sessions.

How do I fix CVE-2017-1217?

To address CVE-2017-1217, ensure that you apply the latest security patches provided by IBM for WebSphere Portal 8.5 and 9.0.

What is the impact of CVE-2017-1217?

CVE-2017-1217 can lead to cross-site scripting attacks that may allow attackers to execute arbitrary JavaScript, potentially compromising user credentials.

Which versions of WebSphere Portal are affected by CVE-2017-1217?

CVE-2017-1217 affects IBM WebSphere Portal versions 8.5 and 9.0.

Has CVE-2017-1217 been exploited in the wild?

There have been no confirmed reports of exploitation of CVE-2017-1217 in the wild, but the vulnerability should be mitigated to prevent potential attacks.

Vulnerability/
CVE-2017-1217

medium

6.1

CWE

28/6/2017

5/8/2024

CVE-2017-1217: XSS

First published: Wed Jun 28 2017(Updated: )

IBM WebSphere Portal 8.5 and 9.0 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 123857

Credit: psirt@us.ibm.com

Affected Software	Affected Version	How to fix
IBM WebSphere Portal	=8.5
IBM WebSphere Portal	=9.0

Never miss a vulnerability like this again

Reference Links

Frequently Asked Questions

What is the severity of CVE-2017-1217?
CVE-2017-1217 has been rated as a medium severity vulnerability due to its potential impact on user sessions.
How do I fix CVE-2017-1217?
To address CVE-2017-1217, ensure that you apply the latest security patches provided by IBM for WebSphere Portal 8.5 and 9.0.
What is the impact of CVE-2017-1217?
CVE-2017-1217 can lead to cross-site scripting attacks that may allow attackers to execute arbitrary JavaScript, potentially compromising user credentials.
Which versions of WebSphere Portal are affected by CVE-2017-1217?
CVE-2017-1217 affects IBM WebSphere Portal versions 8.5 and 9.0.
Has CVE-2017-1217 been exploited in the wild?
There have been no confirmed reports of exploitation of CVE-2017-1217 in the wild, but the vulnerability should be mitigated to prevent potential attacks.

collector/nvd-index
agent/type
agent/references
agent/softwarecombine
collector/mitre-cve
source/MITRE
agent/weakness
agent/author
agent/last-modified-date
agent/severity
agent/first-publish-date
agent/event
agent/description
agent/tags
agent/source
vendor/ibm
canonical/ibm websphere portal
version/ibm websphere portal/8.5
version/ibm websphere portal/9.0

Company

Resources

Contact

SecAlerts Pty Ltd.
132 Wickham Terrace
Fortitude Valley,
QLD 4006, Australia
info@secalerts.co

By using SecAlerts services, you agree to our services end-user license agreement. This website is safeguarded by reCAPTCHA and governed by the Google Privacy Policy and Terms of Service. All names, logos, and brands of products are owned by their respective owners, and any usage of these names, logos, and brands for identification purposes only does not imply endorsement. If you possess any content that requires removal, please get in touch with us.

Frequently Asked Questions

What is the severity of CVE-2017-1217?
CVE-2017-1217 has been rated as a medium severity vulnerability due to its potential impact on user sessions.
How do I fix CVE-2017-1217?
To address CVE-2017-1217, ensure that you apply the latest security patches provided by IBM for WebSphere Portal 8.5 and 9.0.
What is the impact of CVE-2017-1217?
CVE-2017-1217 can lead to cross-site scripting attacks that may allow attackers to execute arbitrary JavaScript, potentially compromising user credentials.
Which versions of WebSphere Portal are affected by CVE-2017-1217?
CVE-2017-1217 affects IBM WebSphere Portal versions 8.5 and 9.0.
Has CVE-2017-1217 been exploited in the wild?
There have been no confirmed reports of exploitation of CVE-2017-1217 in the wild, but the vulnerability should be mitigated to prevent potential attacks.